Lianhua Qingwen and Other "Three Medicines" Add New Indications for COVID-19, Experts Warn Not to Take If Not Sick
The term "three medicines and three prescriptions" originated from a press conference held by the State Council Information Office on March 23, where "three medicines" refers to Lianhua Qingwen Capsules (Granules), Jinhua Qinggan Granules and Xuebijing Injection. Recently, these three drugs have become the first batch of drugs to be approved for new indications for COVID-19 in China.